Login

Mirati Therapeutics, Inc. 4/A SEC Filings

Filed On Filing
12 Nov 2020 Form 4/A: Reed Vickie S, SVP, Chief Accounting Officer

Granted 2,522 Option Grant (Right to Buy)

16 Jun 2020 Form 4/A: Braslyn Ltd., 10% owner

Sold 600,000 shares ($58.2M) · Received 600,006 shares by exercise or conversion ($600) · Gave up 6 shares to cover exercise price or tax ($604)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support